BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Trevisan K, Cristina-Pereira R, Silva-Amaral D, Aversi-Ferreira TA. Theories of Aging and the Prevalence of Alzheimer's Disease. Biomed Res Int 2019;2019:9171424. [PMID: 31317043 DOI: 10.1155/2019/9171424] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Al-kuraishy HM, Al-gareeb AI, Saad HM, Batiha GE. Benzodiazepines in Alzheimer’s disease: beneficial or detrimental effects. Inflammopharmacol 2022. [DOI: 10.1007/s10787-022-01099-4] [Reference Citation Analysis]
2 Yarns BC, Holiday KA, Carlson DM, Cosgrove CK, Melrose RJ. Pathophysiology of Alzheimer’s Disease. Psychiatric Clinics of North America 2022. [DOI: 10.1016/j.psc.2022.07.003] [Reference Citation Analysis]
3 Siokas V, Stamati P, Pateraki G, Liampas I, Aloizou A, Tsirelis D, Nousia A, Sgantzos M, Nasios G, Bogdanos DP, Dardiotis E. Analysis of SOD2 rs4880 Genetic Variant in Patients with Alzheimer’s Disease. CIMB 2022;44:4406-4414. [DOI: 10.3390/cimb44100302] [Reference Citation Analysis]
4 Irrera N, Barbieri MA, Bagnato G, Ioppolo C, Versace AG. Impact of the COVID-19 Pandemic on Chronic Neurological Disorders: Focus on Patients with Dementia. CNSNDDT 2022;21:1017-1026. [DOI: 10.2174/1871527321666220111124928] [Reference Citation Analysis]
5 Saleem U, Chauhdary Z, Islam S, Zafar A, Khayat RO, Althobaiti NA, Shah GM, Alqarni M, Shah MA. Sarcococca saligna ameliorated D-galactose induced neurodegeneration through repression of neurodegenerative and oxidative stress biomarkers. Metab Brain Dis 2022. [PMID: 35881299 DOI: 10.1007/s11011-022-01046-w] [Reference Citation Analysis]
6 Guo M, Jia J, Zhang J, Zhou M, Wang A, Chen S, Zhao X. Association of β-cell function and cognitive impairment in patients with abnormal glucose metabolism. BMC Neurol 2022;22:232. [PMID: 35739484 DOI: 10.1186/s12883-022-02755-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ivanova O, Meilán JJG, Martínez-sánchez F, Martínez-nicolás I, Llorente TE, González NC. Discriminating speech traits of Alzheimer's disease assessed through a corpus of reading task for Spanish language. Computer Speech & Language 2022;73:101341. [DOI: 10.1016/j.csl.2021.101341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Stanczykiewicz B, Gburek J, Rutkowska M, Lemieszewska M, Gołąb K, Juszczyńska K, Piotrowska A, Trziszka T, Dzięgiel P, Podhorska-okołów M, Zabłocka A, Rymaszewska J. Ovocystatin Induced Changes in Expression of Alzheimer’s Disease Relevant Proteins in APP/PS1 Transgenic Mice. JCM 2022;11:2372. [DOI: 10.3390/jcm11092372] [Reference Citation Analysis]
9 Poudel P, Park S. Recent Advances in the Treatment of Alzheimer’s Disease Using Nanoparticle-Based Drug Delivery Systems. Pharmaceutics 2022;14:835. [DOI: 10.3390/pharmaceutics14040835] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
10 Hosseini L, Sharif Nia H, Ashghali Farahani M. Development and Psychometric Evaluation of Family Caregivers’ Hardiness Scale: A Sequential-Exploratory Mixed-Method Study. Front Psychol 2022;13:807049. [DOI: 10.3389/fpsyg.2022.807049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zaki MO, Elsherbiny DA, Salama M, Azab SS. Potential role of Drug Repositioning Strategy (DRS) for management of tauopathy. Life Sci 2022;291:120267. [PMID: 34974076 DOI: 10.1016/j.lfs.2021.120267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Hosseini L, Sharif Nia H, Ashghali Farahani M. Hardiness in Family Caregivers During Caring From Persons With Alzheimer's Disease: A Deductive Content Analysis Study. Front Psychiatry 2021;12:770717. [PMID: 35069280 DOI: 10.3389/fpsyt.2021.770717] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Villa C, Rivellini E, Lavitrano M, Combi R. Can SARS-CoV-2 Infection Exacerbate Alzheimer's Disease? An Overview of Shared Risk Factors and Pathogenetic Mechanisms. J Pers Med 2022;12:29. [PMID: 35055344 DOI: 10.3390/jpm12010029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
14 Beserra A, Oliveira B, Portugal E, Dutra P, Laks J, Deslandes A, Moraes H. Cortisol Reactivity to a physical stressor in Patients with Depression and Alzheimer's disease. Dement Neuropsychol 2022;16:61-8. [PMID: 35719259 DOI: 10.1590/1980-5764-DN-2021-0066] [Reference Citation Analysis]
15 Kaira M, Walia V, Garg M. Role of Hypertension and Hyperlipidemia in the Pathogenesis of Dementia. Current Thoughts on Dementia 2022. [DOI: 10.1007/978-981-16-7606-2_10] [Reference Citation Analysis]
16 Dong Z, Yang X, Chang L, Song X, Li X, Wang J, Li J. Influence of MRI on Diagnostic Efficacy and Satisfaction of Patients with Alzheimer's Disease. Comput Math Methods Med 2021;2021:9038784. [PMID: 34790255 DOI: 10.1155/2021/9038784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Lai F, Mercaldo ND, Wang CM, Hersch MS, Hersch GG, Rosas HD. Association between Hypothyroidism Onset and Alzheimer Disease Onset in Adults with Down Syndrome. Brain Sci 2021;11:1223. [PMID: 34573243 DOI: 10.3390/brainsci11091223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Fleming V, Piro-Gambetti B, Patrick A, Zammit M, Alexander A, Christian BT, Handen B, Cohen A, Klunk W, Laymon C, Ances BM, Plante DT, Okonkwo O, Hartley SL. Physical activity and cognitive and imaging biomarkers of Alzheimer's disease in down syndrome. Neurobiol Aging 2021;107:118-27. [PMID: 34428720 DOI: 10.1016/j.neurobiolaging.2021.07.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
19 Kovács Z, Brunner B, Ari C. Beneficial Effects of Exogenous Ketogenic Supplements on Aging Processes and Age-Related Neurodegenerative Diseases. Nutrients 2021;13:2197. [PMID: 34206738 DOI: 10.3390/nu13072197] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
20 Gul R, Jan H, Lalay G, Andleeb A, Usman H, Zainab R, Qamar Z, Hano C, Abbasi BH. Medicinal Plants and Biogenic Metal Oxide Nanoparticles: A Paradigm Shift to Treat Alzheimer’s Disease. Coatings 2021;11:717. [DOI: 10.3390/coatings11060717] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
21 Khavinson V, Ilina A, Kraskovskaya N, Linkova N, Kolchina N, Mironova E, Erofeev A, Petukhov M. Neuroprotective Effects of Tripeptides-Epigenetic Regulators in Mouse Model of Alzheimer's Disease. Pharmaceuticals (Basel) 2021;14:515. [PMID: 34071923 DOI: 10.3390/ph14060515] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Xia X, Wang Y, Zheng J. COVID-19 and Alzheimer's disease: how one crisis worsens the other. Transl Neurodegener 2021;10:15. [PMID: 33941272 DOI: 10.1186/s40035-021-00237-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 29.0] [Reference Citation Analysis]
23 Bhattacharya T, Dey PS, Akter R, Kabir MT, Rahman MH, Rauf A. Effect of natural leaf extracts as phytomedicine in curing geriatrics. Exp Gerontol 2021;150:111352. [PMID: 33894308 DOI: 10.1016/j.exger.2021.111352] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 17.0] [Reference Citation Analysis]
24 Lin CH, Chen PK, Wang SH, Lane HY. Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open 2021;4:e216156. [PMID: 33881530 DOI: 10.1001/jamanetworkopen.2021.6156] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
25 Wang Y, Zhang H, Wang J, Yu M, Zhang Q, Yan S, You D, Shi L, Zhang L, Wang L, Wu H, Cao X. Aconiti lateralis Radix Praeparata inhibits Alzheimer's disease by regulating the complex regulation network with the core of GRIN1 and MAPK1. Pharm Biol 2021;59:311-20. [PMID: 33784489 DOI: 10.1080/13880209.2021.1900879] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Librizzi D, Cabanel N, Zavorotnyy M, Riehl E, Kircher T, Luster M, Hooshyar Yousefi B. Clinical Relevance of [18F]Florbetaben and [18F]FDG PET/CT Imaging on the Management of Patients with Dementia. Molecules 2021;26:1282. [PMID: 33652938 DOI: 10.3390/molecules26051282] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
27 Li M, Geng R, Li C, Meng F, Zhao H, Liu J, Dai J, Wang X. Dysregulated gene-associated biomarkers for Alzheimer's disease and aging. Transl Neurosci 2021;12:83-95. [PMID: 33623715 DOI: 10.1515/tnsci-2021-0009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
28 Li Z, Zhang Z, Ren Y, Wang Y, Fang J, Yue H, Ma S, Guan F. Aging and age-related diseases: from mechanisms to therapeutic strategies. Biogerontology 2021;22:165-87. [PMID: 33502634 DOI: 10.1007/s10522-021-09910-5] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 49.0] [Reference Citation Analysis]
29 Raj S, Dsouza LA, Singh SP, Kanwal A. Sirt6 Deacetylase: A Potential Key Regulator in the Prevention of Obesity, Diabetes and Neurodegenerative Disease. Front Pharmacol 2020;11:598326. [PMID: 33442387 DOI: 10.3389/fphar.2020.598326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Li WH, Wei ZW, Liu XF. Clinical efficacy of sertraline in the treatment of depression caused by Alzheimer disease: A protocol of systematic review. Medicine (Baltimore) 2020;99:e23076. [PMID: 33157972 DOI: 10.1097/MD.0000000000023076] [Reference Citation Analysis]
31 Pantiya P, Thonusin C, Chattipakorn N, Chattipakorn SC. Mitochondrial abnormalities in neurodegenerative models and possible interventions: Focus on Alzheimer's disease, Parkinson's disease, Huntington's disease. Mitochondrion 2020;55:14-47. [PMID: 32828969 DOI: 10.1016/j.mito.2020.08.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
32 Sargent L, Nalls M, Amella EJ, Slattum PW, Mueller M, Bandinelli S, Tian Q, Swift-Scanlan T, Lageman SK, Singleton A. Shared mechanisms for cognitive impairment and physical frailty: A model for complex systems. Alzheimers Dement (N Y) 2020;6:e12027. [PMID: 32685657 DOI: 10.1002/trc2.12027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
33 Khan MI, Shin JH, Kim MY, Shin TS, Kim JD. Green Tea Seed Isolated Theasaponin E1 Ameliorates AD Promoting Neurotoxic Pathogenesis by Attenuating Aβ Peptide Levels in SweAPP N2a Cells. Molecules 2020;25:E2334. [PMID: 32429462 DOI: 10.3390/molecules25102334] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
34 Li S, Tang Y. Structural Model for Estimating the Influence of Healthy Lifestyle on Episodic Memory in Adults with Subjective Memory Complaints. Biomed Res Int 2020;2020:8349819. [PMID: 32219143 DOI: 10.1155/2020/8349819] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Uzuegbunam BC, Librizzi D, Hooshyar Yousefi B. PET Radiopharmaceuticals for Alzheimer's Disease and Parkinson's Disease Diagnosis, the Current and Future Landscape. Molecules 2020;25:E977. [PMID: 32098280 DOI: 10.3390/molecules25040977] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 18.0] [Reference Citation Analysis]
36 Romanchuk P, Volobuev A. Modern Tools and Methods of Epigenetic Protection of Healthy Aging and Longevity of the Homo sapiens. BSP 2020;6:43-70. [DOI: 10.33619/2414-2948/50/06] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
37 Kalinovic R, Dinescu M, Vlad G, Neda-stepan O, Enătescu V. The efficacy of neurotrophic factors in the treatment of cases with mixed vascular and Alzheimer’s dementia, with multiple chronic comorbidities. Psihiatru ro 2020;4:26. [DOI: 10.26416/psih.63.4.2020.3958] [Reference Citation Analysis]